NorthStar Medical Radioisotopes announced that construction on its isotope processing facility in Beloit is complete and equipment is being installed. The plant will produce molybdenum-99 (Mo-99) used in medical imaging.
In a release, Stephen Merrick, president/CEO of NorthStar said: “Construction completion of our Beloit, Wis. Mo-99 processing facility is a significant marker of NorthStar’s progress, as we continue to execute on our plan to meet customer demand and ensure reliable, non-uranium based radioisotope supply for the United States.”
